Hong Kong Pharma Digital Technology (HKPD) said Thursday it closed initial public offering of 1.4 million ordinary shares at $4 each, including 1 million by the company and 403,685 by selling shareholders.
The IPO raised $5.6 million in gross proceeds, including $4 million for the company and $1.6 million for selling shareholders.
The shares started trading on the Nasdaq Capital Market under the ticker symbol "HKPD" on Wednesday.
The company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 150,000 shares.
Hong Kong Pharma provides over-the-counter pharmaceutical cross-border e-commerce supply chain services in Hong Kong. It plans to use proceeds toward upgrading enterprise resource planning systems, acquiring warehouse equipment, expanding sales and marketing team, and general corporate needs.
Shares were up nearly 3% in recent trading.
Price: 2.90, Change: +0.08, Percent Change: +2.84
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。